CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company
Dianthus Therapeutics, Inc. /DE/
Sign in to watch- Ticker
- DNTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 929-999-4055
- Business address
- 7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
- Former names
- Magenta Therapeutics, Inc.
- S-1/A Offering Registration Statement
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Auditor change
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
- 4 Open-market buy Director bought 24,670 shares at $13.63 ($336,252)
- 4 Open-market buy Director bought 30,000 shares at $13.15 ($394,500)
- 4 Open-market buy Chief Medical Officer bought 4,000 shares at $13.20 ($52,800)
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 30,000 shares at $13.20 ($396,000)
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K/A Event Results of operations · Executive or director change · Other events
- SC 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
Page 13 of 33 · 660 filings